Department of Carcinogenesis and The University of Texas Graduate School of Biomedical Sciences at Houston, The University of Texas M. D. Anderson Cancer Center, Science Park-Research Division, Smithville, Texas 78957, USA.
Environ Mol Mutagen. 2010 Jul;51(6):520-6. doi: 10.1002/em.20569.
Although various schemes for interstrand crosslink (ICL) repair incorporate DNA recombination, replication, and double-strand break intermediate steps, action of the nucleotide excision repair (NER) system or some variation of it is a common feature of most models. In the bacterium Escherichia coli, the NER enzyme UvrABC can incise on either side of an ICL to unhook the crosslink, and can proceed via a subsequent recombination step. The relevance of NER to ICL repair in mammalian cells has been challenged. Of all NER mutants, it is clear that ERCC1 and XPF-defective cells show the most pronounced sensitivities to ICL-inducing agents, and defects in ICL repair. However, there is good evidence that cells defective in NER proteins including XPA and XPG are also more sensitive than normal to ICL-inducing agents. These results are summarized here, together with evidence for defective crosslink removal in NER-defective cells. Studies of incision at sites of ICL by cell extracts and purified proteins have been done, but these studies are not all consistent with one another and further research is required.
虽然各种交联(ICL)修复方案都包含 DNA 重组、复制和双链断裂中间体步骤,但核苷酸切除修复(NER)系统或其某种变体的作用是大多数模型的共同特征。在细菌大肠杆菌中,NER 酶 UvrABC 可以在 ICL 的任一侧切割以解开交联,并且可以通过随后的重组步骤进行。NER 与哺乳动物细胞中 ICL 修复的相关性一直受到质疑。在所有 NER 突变体中,很明显 ERCC1 和 XPF 缺陷细胞对 ICL 诱导剂和 ICL 修复显示出最明显的敏感性缺陷。然而,有充分的证据表明,包括 XPA 和 XPG 在内的 NER 蛋白缺陷细胞对 ICL 诱导剂也比正常细胞更敏感。这些结果在这里进行了总结,同时还提供了 NER 缺陷细胞中交联去除缺陷的证据。已经对细胞提取物和纯化蛋白中 ICL 位点的切口进行了研究,但这些研究并不完全一致,需要进一步研究。